Novartis India Ltd vs Sun Pharmaceutical Industries Ltd
Side-by-side stock comparison based on AI earnings call analysis
Which stock has stronger management signals?
Novartis India Ltd currently has the stronger revenue growth signal.
Novartis India Ltd show active capex signals based on earnings call analysis.
No strong fundraising signal is currently visible for either company.
| Metric | Novartis India Ltd | Sun Pharmaceutical Industries Ltd |
|---|---|---|
| Current Price | ₹2,047 | ₹1,837 |
| Market Cap | ₹5,904.31 Cr. | ₹4.41 L Cr. |
| Industry | Pharmaceuticals & Biotechnology | Pharmaceuticals & Biotechnology |
| P/E Ratio | 60.39 | 34.95 |
| ROE (%) | 11.63 | 15.95 |
| Debt/Equity | — | 0.06 |
| Sales Growth 5Y (%) | -1.46 | 11.78 |
| Profit Growth 5Y (%) | 160.63 | 2.54 |
| Promoter Holding (%) | 70.68 | 54.48 |
| Revenue Rank | Rank 2 | Rank 3 |
| Margin Rank | Rank 3 | Rank 3 |
| Signal | — | — |
| Capex | Yes | No information |
| Fundraise | No information | No information |